Emerging sinusitis treatments include monoclonal antibodies to tackle the unmet medical needs of patients.
The post A clearer path to relief: sinusitis treatments on the way appeared first on
Subscribe to Labiotech.eu’s news feed.
Click on “Follow” and decide if you want to get news from Labiotech.eu via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to Labiotech.eu comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from Labiotech.eu which you are really interested in. Click on the blue “Filter” button below to get started.
Title: Labiotech.eu
Is this your feed? Claim it!
Emerging sinusitis treatments include monoclonal antibodies to tackle the unmet medical needs of patients.
The post A clearer path to relief: sinusitis treatments on the way appeared first on
Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff is driving deals.
The post What does 2026 hold for the biotech industry? appeared first on
Today, we're thrilled to have Tim Opler, a leading voice in biotech investment banking.
The post Top 5 trends that will drive biopharma in the next decade with Tim Opler appeared first on
Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool.
The post Could CRISPR really cure these diseases? appeared first on
Find out whether we are closing in on a cure for hepatitis B - a virus affecting the liver that can cause acute and chronic disease.
The post Hepatitis B: Are we edging closer to a cure? appeared first on